Olive
AI-powered healthcare operations platform
Company profile
Company profile
Olive was a healthcare artificial intelligence company that developed automation solutions for healthcare administrative and operational workflows. The company built AI-powered tools designed to reduce administrative burden, streamline revenue cycle management, and improve operational efficiency for hospitals, health systems, and other healthcare organizations. Olive's platform aimed to automate repetitive tasks such as insurance eligibility verification, prior authorization, claims processing, and other back-office functions that traditionally consumed significant staff time and resources. The company positioned itself as an AI workforce that could integrate with existing healthcare IT systems to handle high-volume administrative tasks. However, Olive ceased independent operations and its technology assets were acquired by other healthcare technology companies. The company's journey reflects both the promise and challenges of applying AI automation to complex healthcare administrative processes.
Company description Olive official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Company milestones
Company ceased independent operations and assets were acquired
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered healthcare operations platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Nature cardiovascular research · Sep 1, 2026
Controversies in ophthalmology: challenges and crossroads in 2026.Current opinion in ophthalmology · Sep 1, 2026
Performance and Projected Impact of Synovial Fluid Polymerase Chain Reaction Testing for Patients Evaluated for Septic Arthritis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · Aug 31, 2026
Correction: Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver Disease.Digestive diseases and sciences · Aug 31, 2026
Streamlined LC-HRMS-based determination of sterols and triterpenic alcohols in edible oils for authentication purposes.Journal of chromatography. A · Aug 30, 2026
A Skills-Based Longitudinal Intervention for Clinician Educators: Addressing Implicit Bias in Patient Care and the Clinical Learning Environment.The Journal of continuing education in the health professions · Aug 28, 2026
Clinical validation
NCT05310838 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Olive's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize hospital operations, automate administrative workflows, improve scheduling, manage healthcare resources, coordinate care delivery, or reduce operational inefficiencies. Includes prior authorization automation, credentialing, billing, care coordination, and AI tools that help health systems run more efficiently.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.